Trial results provide a strong foundation for seeking authorization of the vaccine for children 5 to 11 years old. The clinical trial data of COVID vaccine will be submitted to regulatory authorities for school-aged children before the start of the winter season
from Top Health News | Latest Health & Healthcare Industry Information and Updates: ET HealthWorld : ETHealthworld.com https://ift.tt/2ZiRcxC
Home »
Top Health News | Latest Health & Healthcare Industry Information and Updates: ET HealthWorld : ETHealthworld.com
» Pfizer and BioNTech get positive results in phase 2/3 trial of COVID-19 Vax for children 5 to 11 years
https://ift.tt/eA8V8J
No comments:
Post a Comment